Publications

CHMP Favors EU Approval of Keytruda for Advanced Melanoma Patients with Complete Tumor Resection

December 14, 2018

Source: Immuno-oncology News, December 2018 The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency (EMA), has recommended the approval of Keytruda(pembrolizumab) for the treatment of…

BRIEF—Health Canada added approval for Tafinlar plus Mekinist combo

December 10, 2018

Melanoma News, Regulatory, Publications

Source: The Pharma Letter, December 2018 Pharma regulator Health Canada has approved the use of a combination of two Novartis cancer therapies as targeted treatment to prevent recurrence of melanoma…

Melanoma Journal Articles for October 2018

November 29, 2018

Scientific Publications

Cancer Epidemiology, Biomarkers and Prevention Reviews An Epidemiological Review of Diet and Cutaneous Malignant Melanoma Keming Yang, Teresa T. Fung and Hongmei Nan DOI: 10.1158/1055-9965.EPI-18-0243 Published October 2018 BMJ Cancer genetics Short report Efficacy of novel immunotherapy regimens in…

European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

October 29, 2018

Melanoma News, Regulatory, Publications

Source: Hospital Healthcare Europe, October 2018 The European Commission (EC) had approved the use of BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) to treat adults with advanced BRAF-mutant melanoma. The EC’s decision is…

Publications

CHMP Favors EU Approval of Keytruda for Advanced Melanoma Patients with Complete Tumor Resection

BRIEF—Health Canada added approval for Tafinlar plus Mekinist combo

Melanoma Journal Articles for October 2018

European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

MRV News

Melanoma News

Archive

Our Partners

Melanoma Research Victoria

Quick Links